Skip to main content
. 2022 May;11(5):757–775. doi: 10.21037/tlcr-22-300

Table 3. Results of univariate and multivariate Cox regression analysis for PFS (univariate analysis of the significant variables).

Variables Progression
Univariate Multivariate
HR 95% CI P value HR 95% CI P value
Types of pathology 1.953 1.180–3.231 0.009* 2.103 1.237–3.576 0.006*
ECOG PS
   2 1 1
   1 0.096 0.024–0.388 0.001* 0.099 0.024–0.411 0.001*
   0 0.177 0.052–0.601 0.006* 0.221 0.062–0.794 0.021*
CEA6W 1.758 1.066–2.900 0.027* 1.810 1.091–3.003 0.022*
PLT12W 1.754 1.044–2.918 0.034* 1.607 0.995–2.703 0.074

*, P<0.05. PFS, progression-free survival; ECOG PS, Eastern Cooperative Oncology Group performance status; CEA, carcinoembryonic antigen; PLT, platelet; HR, hazard ratio; CI, confidence interval.